Insights
Farient’s latest executive compensation leadership
Through its research, blogs, and commentary, Farient is driving the conversation on executive compensation and governance issues.
March 7, 2017
Bloomberg – Health Insurers Would Get Fatter Tax Break on CEO Pay Under GOP Health Plan
John Trentacoste, director at Farient Advisors, speaks to Bloomberg about the implications of the proposed bill to replace Obamacare on health insurance companies.
Read MoreMarch 1, 2017
FCPA Blog – How perverse incentives distort individual and corporate performance
Mark Hodak, a partner at Farient Advisors, explores how even good, ethical employees can succumb to perverse incentives due to the pressure to meet internal targets.
Read MoreFebruary 21, 2017
Agenda – Boards Move to Lessen Impact of TSR, Experts Say
While the use of relative total shareholder return (TSR) has increased in recent years, there are signs that boards are nevertheless trying to lessen its impact on their long-term incentive plans. Some boards have started to de-emphasize TSR in their incentive plans, and going forward, experts say TSR usage could flatten out or even decline.
Read MoreFebruary 13, 2017
FCPA Blog – Revisiting EpiPen: Steep incentive thresholds are corporate disasters waiting to happen
Marc Hodak, partner at Farient Advisors, explains how steep incentive thresholds were behind the Epipen scandal and how companies can learn from Mylan’s mistake.
Read MoreFebruary 6, 2017
Agenda – Comp Committees Move on Refreshment
Boards are being urged to focus on refreshing their compensation committees to ensure there is the right balance of skills and experience to support the overall corporate strategy, experts say. Failure to sufficiently refresh the compensation committee over time, they say, could cause pay programs to suffer, lead to discontent among investors and even have consequences for director votes.
Read More